PLSE - Pulse Biosciences, Inc.
About Pulse Biosciences, Inc. (https://www.pulsebiosciences.com)
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Darrin R. Uecker | Chief Technology Officer & Director | 1966 | $869,889 USD |
| Paul Arthur LaViolette | President, Chief Executive Officer & Co-Chairman of the Board | 1958 | $765,068 USD |
| Jon Skinner | Chief Financial Officer | 1986 | $459,898 USD |
| David Danitz | Senior Vice President of Engineering | – | – |
| Gansevoort Dunnington | Chief Medical Officer | – | – |
| Kenneth Stratton | General Counsel & Corporate Secretary | 1969 | – |
| Liane Teplitsky | Chief Operating Officer | 1977 | – |
| Niv Ad | Chief Science Officer of Cardiac Surgery | – | – |
| Patty Perla | Vice President of Human Resources | – | – |
| Steven T. Weber | Vice President of Accounting, Principal Accounting Officer & Global Corporate Controller | 1976 | – |